#IMFINZI hashtag - Bluesky

@pharmaphorum.bsky.social

2 weeks ago

AZ piles pressure on MSD et al in gastric cancer AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage gastric cancer.

#AstraZeneca's cancer immunotherapy #Imfinzi has been approved in the #EU for use before and after surgery for early-stage #gastriccancer, consolidating its position in the disease after picking up approval in the US toward the end of last year.

0 0 0 0

Drugs.com

@drugs.com

4 months ago

What type of drug is Imfinzi? Official answer: Imfinzi (durvalumab) is a programmed death-ligand 1 (PD-L1) blocking antibody (also called an immune checkpoint...

#Imfinzi (durvalumab) treats multiple cancers by blocking PD-L1, preventing cancer cells from deactivating immune T-cells. This immune checkpoint inhibitor boosts the body's natural cancer-fighting response for lung, liver, biliary, endometrial, and bladder cancers.

0 0 0 0

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

6 months ago

NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer - PharmaTimes Imfinzi and Imjudo combination recommended as first-line treatment

#oncology #NICE #AstraZeneca #dualimmunotherapy #advancedlivercancer #livercancer #Imfinzi #durvalumab #Imjudo #tremelimumab #Advancedhepatocellularcarcinoma #unresectablehepatocellularcarcinoma #HCC #NICEapproval #STRIDEregimen #primarylivercancer #BritishLiverTrust
zurl.co/M3ftp

0 0 0 0

@drtimos.bsky.social

8 months ago

Oncology Weekly News – July 7th 2025 🔬🧬 Oncology Updates: Glioma Drug Win, HER2+ Cancer Trials, First-in-Class ADC and More From FDA orphan drug designations to pivotal […] The post Oncology Weekly News – July 7th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Oncology Weekly News – July 7th 2025 #News #Imfinzi #Oncology #clinicaltrials Comment below!

0 0 0 0

@drtimos.bsky.social

8 months ago

Oncology Weekly News – July 7th 2025 🔬🧬 Oncology Updates: Glioma Drug Win, HER2+ Cancer Trials, First-in-Class ADC and More From FDA orphan drug designations to pivotal […] The post Oncology Weekly News – July 7th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Oncology Weekly News – July 7th 2025 #News #Imfinzi #Oncology #clinicaltrials Comment below!

0 0 0 0

@drtimos.bsky.social

8 months ago

Oncology Weekly News – July 7th 2025 🔬🧬 Oncology Updates: Glioma Drug Win, HER2+ Cancer Trials, First-in-Class ADC and More From FDA orphan drug designations to pivotal […] The post Oncology Weekly News – July 7th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Oncology Weekly News – July 7th 2025 #News #Imfinzi #Oncology #clinicaltrials Comment below!

0 0 0 0

Profit Trading USA

@profittradingusa.bsky.social

10 months ago

Imfinzi gets EU recommendation for bladder cancer treatment Blog Mobile Portfolio Widgets About Us Advertise Help & Support Authors Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Click Subscribe #Imfinzi #BladderCancer #CancerTreatment #EUApproval #Oncology

0 0 0 0

Onco404

@onco404.bsky.social

10 months ago

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌

Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.

#Onco404 #Cancer #Kanser #MedSky #ImmuneCheckpointInhibitor #Immunotherapy #Keytruda #Opdivo #Yervoy #Imfinzi #Jemperli #Vocabulary

1 1 0 0

Raffaella Ravinetto

@rravinetto.bsky.social

10 months ago

Medical Product Alert N°3/2025: Falsified IMFINZI (durvalumab) injection 500mg/10ml Alert SummaryThis WHO Medical Product Alert refers to three batches of falsified IMFINZI (durvalumab) injection 500mg/10ml. The falsified products have been detected in the Islamic Republic of Iran an...

A @who.int Medical Product Alert about #falsified #IMFINZI (#durvalumab) injection, detected in the Islamic Republic of #Iran and #Türkiye. The genuine product is for Non-Small Cell #Lung #Cancer in adults, so #harm to #health from the falsification can be huge:
www.who.int/news/item/14...

2 2 0 0

pharmaphorum

@pharmaphorum.bsky.social

10 months ago

AZ plots wider Imfinzi use in bladder cancer after trial win AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in early bladder cancer

NEWS: Find out why #AstraZeneca could have its work cut out growing #Imfinzi in bladder cancer, despite a positive trial readout.

pharmaphorum.com/news/az-plot...

0 0 0 0